S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy

Titan Pharmaceuticals (TTNP) SEC Filings & 10K Form

$7.26
+0.10 (+1.40%)
(As of 04/12/2024 ET)

Recent Titan Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/05/2024
3:34 PM
Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13D/A
04/05/2024
9:13 AM
Flores Francisco (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/05/2024
9:14 AM
Mokhtar Firdauz (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2024
8:45 AM
Choong Choon Hau (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
11:19 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
3:59 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:13 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
3:05 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:15 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
3:23 PM
Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:25 PM
Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:29 PM
Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:31 PM
McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:33 PM
NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2023
4:26 PM
Titan Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/23/2023
2:07 PM
Chiam Brynner (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
4:08 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
4:30 PM
Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13D
10/04/2023
3:40 PM
Shen Seow Gim (Reporting)
Sire Group Ltd. (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2023
3:41 PM
Titan Pharmaceuticals (Filer)
Form 8-K/A
09/18/2023
3:45 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2023
4:30 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
3:28 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
4:08 PM
Titan Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2023
7:06 PM
Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
6:42 PM
McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4/A
07/31/2023
6:44 PM
Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4/A
07/31/2023
6:45 PM
NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4/A
07/31/2023
6:38 PM
Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
6:39 PM
Lazar David E. (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:42 PM
NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:43 PM
McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:45 PM
Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:47 PM
Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
8:57 PM
Choong Choon Hau (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13D
07/20/2023
8:57 PM
Choong Choon Hau (Reporting)
Titan Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/07/2023
9:28 AM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
3:15 PM
Titan Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
4:28 PM
Titan Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
Analysts Predict Price Tag for Gold to TRIPLE (Ad)

Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!

Read Colonial Metals' new Precious Metals Investment Guide.
06/23/2023
3:05 PM
Activist Investing LLC (Filed by)
Titan Pharmaceuticals (Subject)
Form SC 13D/A
06/23/2023
3:07 PM
Activist Investing LLC (Reporting)
Lazar David E. (Reporting)
Titan Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
9:17 AM
Titan Pharmaceuticals (Filer)
Form ARS
05/19/2023
8:30 AM
Titan Pharmaceuticals (Filer)
Form DEFA14A
05/19/2023
8:22 AM
Titan Pharmaceuticals (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TTNP) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners